BR0317882A - Processo para fabricação de lipossomas de longa circulação não tratados com peg; lipossoma; composição de doxorrubicina lipossomal de longa duração não tratada com peg; e método - Google Patents

Processo para fabricação de lipossomas de longa circulação não tratados com peg; lipossoma; composição de doxorrubicina lipossomal de longa duração não tratada com peg; e método

Info

Publication number
BR0317882A
BR0317882A BR0317882-0A BR0317882A BR0317882A BR 0317882 A BR0317882 A BR 0317882A BR 0317882 A BR0317882 A BR 0317882A BR 0317882 A BR0317882 A BR 0317882A
Authority
BR
Brazil
Prior art keywords
long
liposome
peg
pegylated
liposomal doxorubicin
Prior art date
Application number
BR0317882-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Gautam Vinod Daftary
Srikanth Annappa Pai
Sangeeta Hanurmesh Rivankar
Original Assignee
Bharat Serums & Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Serums & Vaccines Ltd filed Critical Bharat Serums & Vaccines Ltd
Publication of BR0317882A publication Critical patent/BR0317882A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277Preparation processes; Proliposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277Preparation processes; Proliposomes
    • A61K9/1278Post-loading, e.g. by ion or pH gradient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR0317882-0A 2002-12-31 2003-12-31 Processo para fabricação de lipossomas de longa circulação não tratados com peg; lipossoma; composição de doxorrubicina lipossomal de longa duração não tratada com peg; e método BR0317882A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1101MU2002 2002-12-31
PCT/IN2003/000424 WO2004058140A2 (en) 2002-12-31 2003-12-31 Non-pegylated long-circulating liposomes

Publications (1)

Publication Number Publication Date
BR0317882A true BR0317882A (pt) 2005-12-13

Family

ID=32500467

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0317882-0A BR0317882A (pt) 2002-12-31 2003-12-31 Processo para fabricação de lipossomas de longa circulação não tratados com peg; lipossoma; composição de doxorrubicina lipossomal de longa duração não tratada com peg; e método

Country Status (18)

Country Link
EP (1) EP1435231B8 (https=)
JP (1) JP5355842B2 (https=)
KR (2) KR101133084B1 (https=)
CN (1) CN1756533B (https=)
AT (1) ATE453381T1 (https=)
AU (1) AU2003303368B2 (https=)
BR (1) BR0317882A (https=)
CA (1) CA2511464C (https=)
DE (1) DE60330745D1 (https=)
DK (1) DK1435231T3 (https=)
EA (1) EA008930B1 (https=)
ES (1) ES2337563T3 (https=)
IL (1) IL169364A (https=)
MX (1) MXPA05007102A (https=)
NZ (1) NZ540778A (https=)
PT (1) PT1435231E (https=)
WO (1) WO2004058140A2 (https=)
ZA (1) ZA200504850B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5634862B2 (ja) * 2007-05-16 2014-12-03 カーテーベー トゥモーアフォルシュングス ゲゼルシャフト ミット ベシュレンクテル ハフツング 低粘度アントラサイクリン製剤
ES2593027T3 (es) * 2009-03-30 2016-12-05 Eisai R&D Management Co., Ltd. Composición liposomal
EP2415464B1 (en) 2009-03-30 2017-05-10 Eisai R&D Management Co., Ltd. Method for producing liposome composition
WO2012118376A1 (en) * 2011-03-01 2012-09-07 To-Bbb Holding B.V. Advanced active liposomal loading of poorly water-soluble substances
KR102666251B1 (ko) * 2014-11-25 2024-05-27 큐라디즘 약학적 조성물, 이의 제조 및 용도
US12029724B2 (en) 2016-04-28 2024-07-09 Eisai R&D Management Co., Ltd. Method for inhibiting tumor growth
RU2758669C2 (ru) * 2016-09-27 2021-11-01 Вертекс Фармасьютикалз Инкорпорейтед Способ лечения рака с применением сочетания днк-поражающих агентов и ингибиторов днк-пк
US11083705B2 (en) 2019-07-26 2021-08-10 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor
US12036204B2 (en) 2019-07-26 2024-07-16 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor
CN116570775B (zh) * 2023-05-16 2024-08-02 万瑞飞鸿(北京)医疗器材有限公司 一种药物涂层、血管支架及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
EP0153955A1 (en) * 1983-09-06 1985-09-11 Health Research, Inc. Liposome delivery method for decreasing the toxicity of an antitumor drug
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
CA1270198A (en) * 1984-08-08 1990-06-12 Marcel B. Bally Encapsulation of antineoplastic agents in liposomes
US4920016A (en) 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
CA1338702C (en) * 1987-03-05 1996-11-12 Lawrence D. Mayer High drug:lipid formulations of liposomal- antineoplastic agents
JPH0720857B2 (ja) 1988-08-11 1995-03-08 テルモ株式会社 リポソームおよびその製法
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
US6132763A (en) 1988-10-20 2000-10-17 Polymasc Pharmaceuticals Plc Liposomes
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
CA2263455C (en) * 1996-08-23 2002-10-29 Sequus Pharmaceuticals, Inc. Liposomes containing a cisplatin compound
BR9914601A (pt) * 1998-09-16 2001-10-23 Alza Corp Inibidor de topoisomerase capturado por lipossoma
KR20000061075A (ko) * 1999-03-23 2000-10-16 린 중친 리포솜의 응집을 방지하기 위한 방법 및 조성물
GB0111279D0 (en) * 2001-05-10 2001-06-27 Nycomed Imaging As Radiolabelled liposomes

Also Published As

Publication number Publication date
EP1435231B1 (en) 2009-12-30
KR20110075051A (ko) 2011-07-05
AU2003303368B2 (en) 2010-06-17
EA200500850A1 (ru) 2006-02-24
JP2006513189A (ja) 2006-04-20
WO2004058140B1 (en) 2004-12-16
EA008930B1 (ru) 2007-08-31
CN1756533A (zh) 2006-04-05
NZ540778A (en) 2008-04-30
WO2004058140A3 (en) 2004-10-28
KR101133084B1 (ko) 2012-04-04
CN1756533B (zh) 2010-06-16
CA2511464C (en) 2011-08-23
EP1435231A1 (en) 2004-07-07
KR101171045B1 (ko) 2012-08-03
EP1435231B8 (en) 2010-03-03
KR20050088233A (ko) 2005-09-02
PT1435231E (pt) 2010-04-08
ES2337563T3 (es) 2010-04-27
AU2003303368A1 (en) 2004-07-22
HK1089946A1 (en) 2006-12-15
ATE453381T1 (de) 2010-01-15
CA2511464A1 (en) 2004-07-15
IL169364A (en) 2012-05-31
ZA200504850B (en) 2006-08-30
DE60330745D1 (de) 2010-02-11
JP5355842B2 (ja) 2013-11-27
IL169364A0 (en) 2007-07-04
WO2004058140A2 (en) 2004-07-15
MXPA05007102A (es) 2005-08-26
DK1435231T3 (da) 2010-04-26

Similar Documents

Publication Publication Date Title
BR0317882A (pt) Processo para fabricação de lipossomas de longa circulação não tratados com peg; lipossoma; composição de doxorrubicina lipossomal de longa duração não tratada com peg; e método
AR023055A1 (es) Una formulacion farmaceutica de liposoma mixta con vesiculas multilaminar y un proceso para su preparacion
HUP9800460A3 (en) Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy or diagnosis, products and kits comprising thereof and method of in vitro diagnosis by their using
ES2088385T3 (es) Formulaciones de liposomas con una elevada relacion agente antineoplasico/lipido.
WO2003000227A3 (en) A method for preparation of vesicles loaded with biological material and different uses thereof
DE69614385D1 (de) Verfahren zur herstellung einer liposomen-zubereitung
DE69207603D1 (de) Zusammensetzung und verfahren zur behandlung von zystischer fibrose
PT87270A (pt) Processo para a preparacao de 4-de-metoxi-4-amino-antraciclinas
IT1283417B1 (it) Procedimento per alimentare una miscela liquida al cilindro mantecatore di una macchina per la produzione di gelato soft e
HU903559D0 (en) Process for the production of liposome and lipid complex preparations
IT8812585A0 (it) Preparato, in particolare preparato cosmetico antisolare, nonche' metodo per l'introduzione di una sostanza attiva nella pelle
ATE292957T1 (de) Liposomen enthaltend eine eingeschlossene verbindung in übersattigter lösung
DE69902791D1 (de) Polyoxypropylenpolyoxyethylen-vitamin e und seine herstellung
CA2175471A1 (en) Sucrose distearate lipid vesicles
PT90362A (pt) Metodo para o tratamento de doencas muco-epiteliais e da pele em mamiferos que utiliza acidos 4-quinolinocarboxilicos e seus derivados e processo para a preparacao de composicoes farmaceuticas que contem os mesmos compostos
BR9602149A (pt) Compostos medicamento processo para manufatura e uso de esteres de ácido sulfúrico de açúcares amínicos
BR9606528A (pt) Composto sal de um composto processo para a preparação de um composto composição farmacêutica produto uso de um composto e método para o tratmento de um mamífero que necessita de um agente antineoplásico
DE3878922D1 (de) Mehrstufen-einkapselungs/ladeverfahren zur herstellung von lipophile heilmittel enthaltenden liposomen.
RU2006141254A (ru) Ингибиторы холинэстеразы в липосомах, а также их получение и применение
AR006345A1 (es) Una composicion farmaceutica para administracion oral que comprende un inhibidor de proteasa del vih y un derivado de tocoferol soluble en agua, y un metodo para preparar dicha composicion.
BR9917389A (pt) Formulações tópicas compreendendo agentes de penetração na pele e o uso das mesmas
Wertz Liposome dermatics: Chemical aspects of the skin lipid approach
WO1989005636A1 (en) Spontaneous vesiculation of multilamellar liposomes
PT1189932E (pt) Derivados de echinocandina processo para a sua preparacao e sua utilizacao como agentes antifungicos
BR9510250A (pt) Sal de diclavulanato processo para preparar sal de ácido clavulânico e composição farmacêutica

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BSV RESEARCH AND DEVELOPMENT PRIVATE LIMITED (IN)

Free format text: TRANSFERIDO DE: BHARAT SERUMS AND VACCINES LIMITED

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25F Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement

Owner name: BSV RESEARCH AND DEVELOPMENT PRIVATE LIMITED (IN)

Free format text: A FIM DE ATENDER AS DUAS ALTERACOES DE NOME E UMA DE ENDERECO REQUERIDAS ATRAVES DA PETICAO NO 20120116376/RJ, DE 14/12/2012, E NECESSARIO APRESENTAR MAIS UMA GUIA RELATIVA AO TERCEIRO SERVICO SOLICITADO, ALEM DA GUIA DE CUMPRIMENTO DE EXIGENCIA.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2342 DE 24-11-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B25E Requested change of name of applicant rejected

Owner name: BSV RESEARCH AND DEVELOPMENT PRIVATE LIMITED (IN)

B25H Request for change of headquarter rejected

Owner name: BSV RESEARCH AND DEVELOPMENT PRIVATE LIMITED (IN)